-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Zymeworks, Raises Price Target to $38

Benzinga·08/26/2026 15:39:10
语音播报
Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $37 to $38.